Serum Cholesterol Levels and Six-Year Mortality from Stroke in 350,977 Men Screened for the Multiple Risk Factor Intervention Trial

New England Journal of Medicine

Volumn 320, Issue 14, 1989, Pages 904-910

  Iso, Hiroyasu ^a   Jacobs, David R ^a   Wentworth, Deborah ^b   Neaton, James D ^c   Cohen, Jerome D ^c  

^a New Jersey Dept Hlth and Sr Serv   (United States)

^b Division of Biometry   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CHOLESTEROL BLOOD LEVEL; FOLLOW UP; HUMAN; MALE; MORTALITY; PRIORITY JOURNAL; STROKE; UNITED STATES;

EID: 0024519925     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198904063201405     Document Type: Article

References (47)

1. Conference on the Health Effects of Blood Lipids.: optimal distributions for populations.: workshop report.: laboratory-epidemiological section.: American Health Foundation, April 11 and 12, 1979. Prev Med 1979; 8.: 715-32.
2. WHO Expert Committee on Prevention of Coronary Heart Disease. Prevention of coronary heart disease. World Health Organization Technical Report Series 678. Geneva.: World Health Organization, 1982.
3. Atherosclerosis Study Group. Optimal resources for primary prevention of atherosclerotic diseases. Circulation 1984; 70.:(1)155A-205A.
4. Stamler J, Wentworth D, Neaton JD. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356 222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA 1986; 256.: 2823-8.
5. Komachi Y, Iida M, Ozawa H, et al. Risk factors of stroke. Saishin Igaku 1977; 32.: 2264-9.
6. Ueshima H, Iida M, Shimamoto T, et al. Multivariate analysis of risk factor for stroke.: eight-year follow-up study of farming villages in Akita, Japan. Prev Med 1980; 9.: 722-40.
7. Kagan A, Popper JS, Rhoads GG. Factors related to stroke incidence in Hawaiian Japanese men, the Honolulu Heart Study. Stroke 1980; 11.: 14-21.
8. Tanaka H, Ueda Y, Hayashi M, et al. Risk factors for cerebral hemorrhage and cerebral infarction in a Japanese rural community. Stroke 1982; 13.: 62-73.
9. Kannel WB, Dawber TR, Cohen ME, McNamara PM. Vascular disease of the brain — epidemiologic aspects.: the Framingham Study. Am J Public Health 1965; 55.: 1355-66.
10. Heyman A, Karp HR, Heyden S, et al. Cerebrovascular disease in the biracial population of Evans County, Georgia. Arch Intern Med 1971; 128.: 949-55.
11. Ostfeld AM, Shekelle RB, Klawans H, Tufo HM. Epidemiology of stroke in an elderly welfare population. Am J Public Health 1974; 64.: 450-8.
12. Neaton JD, Kuller LH, Wentworth D, Borhani NO. Total and cardiovascular mortality in relation to cigarette smoking, serum cholesterol concentration, and diastolic blood pressure among black and white males followed up for five years. Am Heart J 1984; 108.: 759-69.
13. Ooneda G, Yoshida Y, Suzuki K, et al. Smooth muscle cells in the development of plasmatic arterionecrosis, arteriosclerosis, and arterial contraction. Blood Vessels 1978; 15.: 148-56.
14. Yamori Y, Horie R, Ohtaka M, Nara Y, Fukase M. Effect of hypercholesterolaemic diet on the incidence of cerebrovascular and myocardial lesions in spontaneously hypertensive rats (SHR). Clin Exp Pharmacol Physiol 1976; Suppl 3.: 205-8.
15. Sherwin R, Kaelber CT, Kezdi P, Kjelsberg MO, Thomas HE Jr. The multiple risk factor intervention trial (MRFIT). II. The development of the protocol. Prev Med 1981; 10.: 402-25.
16. Widdowson GM, Kuehneman M, DuChene AG, Hulley SB, Cooper GR. Quality control of biochemical data in the Multiple Risk Factor Intervention Trial.: Central Laboratory. Controlled Clin Trials 1986; 7.: 3 Suppl.: 17S-33S.
17. Wentworth DN, Neaton JD, Rasmussen WL. An evaluation of the Social Security Administration master beneficiary record file and the National Death Index in the ascertainment of vital status. Am J Public Health 1983; 73.: 1270-4.
18. Gillum RF, Gomez-Marin O, Kottke TE, et al. Acute stroke in a metropolitan area, 1970 and 1980.: the Minnesota Heart Survey. J Chronic Dis 1985; 38.: 891-8.
19. Walker AE, Robins M, Weinfeld FD. The National Survey of Stroke.: clinical findings. Stroke 1981; 12.: Suppl I.: I-13-I-44.
20. Cox DR. Regression models and life-tables. J R Stat Soc [B] 1972; 34.: 187-220.
21. Corwin LE, Wolf PA, Kannel WB, McNamara PM. Accuracy of death certification of stroke.: the Framingham Study. Stroke 1982; 13.: 818-21.
22. Kuller L. Cerebrovascular disease mortality among Baltimore residents aged 20-64. Am J Public Health 1967; 57.: 2089-103.
23. Du Florey C, Senter MG, Acheson RM. A study of the validity of the diagnosis of stroke in mortality data. II. Comparison by computer of autopsy and clinical records with death certificates. Am J Epidemiol 1969; 89.: 15-24.
24. Olson FE. Norris FD, Hammes LM, Shipley PW. A study of multiple causes of death in California. J Chronic Dis 1962; 15.: 157-70.
25. Kuller L, Blanch T, Havlik R. Analysis of the validity of cerebrovascular disease mortality statistics in Maryland. J Chronic Dis 1967; 20.: 841-51.
26. Kelsey JL, Thompson WD, Evans AS. Methods in observational epidemiology. In.: Lilienfeld AM, ed. Monographs in epidemiology and biostatistics. Vol. 10. New York.: Oxford University Press, 1986.:39-41, 293-7.
27. Szatrowski TP, Peterson AV Jr, Shimizu Y, et al. Serum cholesterol, other risk factors, and cardiovascular disease in a Japanese cohort. J Chronic Dis 1984; 37.: 569-84.
28. Lin CH, Schimizu Y, Kato H, et al. Cerebrovascular diseases in a fixed population of Hiroshima and Nagasaki, with special reference to relationship between type and risk factors. Stroke 1984; 15.: 653-60.
29. Cole FM, Yates PO. The occurrence and significance of intracerebral microaneurysms. J Pathol Bacteriol 1967; 93.: 393-411.
30. Ooneda G, Yoshida Y, Suzuki K, Sekiguchi T. Morphogenesis of plasmatic arterionecrosis as the cause of hypertensive intracerebral hemorrhage. Virchows Arch [Pathol Anat] 1973; 361.: 31-8.
31. Russell RW. How does blood-pressure cause stroke? Lancet 1975; 2.: 1283-5.
32. Bruckdorfer KR, Demel RA, De Gier J, van Deenen LL. The effect of partial replacements of membrane cholesterol by other steroids on the osmotic fragility and glycerol permeability of erythrocytes. Biochim Biophys Acta 1969; 183.: 334-45.
33. Kroes J, Ostwald R. Erythrocyte membranes — effect of increased cholesterol content on permeability. Biochim Biophys Acta 1971; 249.: 647-50.
34. Konishi M, Terao A, Doi M, et al. Osmotic resistance and cholesterol content of the erythrocyte membrane in cerebral hemorrhage. Igaku no Ayumi 1982; 120.: 30-2.
35. Donahue RP, Abbott RD, Reed DM, Yano K. Alcohol and hemorrhagic stroke.: the Honolulu Heart Program. JAMA 1986; 255.: 2311-4.
36. Kagan A, Popper JS, Rhoads GG, Yano K. Dietary and other risk factors for stroke in Hawaiian Japanese men. Stroke 1985; 16.: 390-6.
37. Yamori Y, Horie R, Ikeda K, Nara Y, Lovenberg W. Prophylactic effect of dietary protein on stroke and its mechanism. In.: Yamori Y, Lovenberg W, Freis ED, eds. Prophylactic approach to hypertensive diseases. New York.: Raven Press, 1979.:497-504.
38. Kimura N, Nakayama Y, Tashiro H. The 15 year follow-up population survey on cerebrovascular disease in rural Kyushu, Japan. Jpn J Med 1977; 16.: 142-4.
39. Kimura N, Toshima H, Nakayama Y, Takayama K, Tashiro H, Takagi M. Fifteen-year follow-up population survey on stroke.: a multivariate analysis of the risk of stroke in farmers of Tanushimaru and fisherman of Ushibuka. In.: Katz AM. Perspectives in cardiovascular research. Vol. 4. Yamori Y, Lovenberg W, Freis ED, eds. Prophylactic approach to hypertensive diseases. New York.: Raven Press, 1979.:505-10.
40. The Steering Committee of the Physicians' Health Study Research Group. Preliminary report.: findings from the aspirin component of the ongoing Physicians' Health Study. N Engl J Med 1988; 318.: 262-4.
41. Roth GJ, Majerus PW. The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein. J Clin Invest 1975; 56.: 624-32.
42. Goodnight SH Jr, Harris WS, Connor WE, Illingworth DR. Polyunsaturated fatty acids, hyperlipidemia, and thrombosis. Arteriosclerosis 1982; 2.: 87-113.
43. Kannel WB, Wolf PA. Epidemiology of cerebrovascular disease. In.: Ross Russell RW, ed. Vascular disease of the central nervous system. 2nd ed. New York.: Churchill Livingstone, 1983.:1-24.
44. Martin MJ, Hulley SB, Browner WS, Kuller LH, Wentworth D. Serum cholesterol, blood pressure, and mortality.: implications from a cohort of 361 662 men. Lancet 1986; 2.: 933-6.
45. Sherwin RW, Wentworth DN, Cutler JA, Hulley SB, Kuller LH, Stamler J. Serum cholesterol levels and cancer mortality in 361 662 men screened for the Multiple Risk Factor Intervention Trial. JAMA 1987; 257.: 943-8.
46. Lowering blood cholesterol to prevent heart disease. JAMA 1985; 253.: 2080-6.
47. Lenfant C. A new challenge for America.: The National Cholesterol Education Program. Circulation 1986; 73.: 855-6.